MAZE short interest
Maze Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,565,330 |
|---|---|
| Change vs prior report | 887,041 (+15.6%) |
| Change over six months | +68.8% |
| Days to cover | 6.07 (sector: 3.78) |
| Average daily volume | 1,080,934 |
| Rank in Healthcare | #312 of 922 by days to cover |
MAZE short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,565,330 | +15.6% | 6.07 | 1,080,934 |
| 2026-09-15 | 5,678,289 | -4.1% | 10.40 | 546,179 |
| 2026-08-31 | 5,918,321 | -1.2% | 16.05 | 368,764 |
| 2026-08-14 | 5,988,933 | +5.5% | 16.17 | 370,295 |
| 2026-07-31 | 5,678,545 | +2.8% | 15.88 | 357,598 |
| 2026-07-15 | 5,525,278 | -0.0% | 8.48 | 651,947 |
| 2026-06-30 | 5,527,117 | +36.2% | 5.37 | 1,028,368 |
| 2026-06-15 | 4,057,146 | +4.1% | 7.69 | 527,440 |
| 2026-05-29 | 3,897,022 | -1.4% | 8.81 | 442,125 |
| 2026-05-15 | 3,950,970 | -9.2% | 7.41 | 533,249 |
| 2026-04-30 | 4,349,436 | +14.6% | 5.64 | 770,868 |
| 2026-04-15 | 3,795,902 | -2.4% | 3.77 | 1,007,473 |
| 2026-03-31 | 3,890,308 | +8.3% | 2.41 | 1,615,820 |
| 2026-03-13 | 3,591,005 | +4.4% | 6.33 | 566,914 |
| 2026-02-27 | 3,438,552 | +2.5% | 10.35 | 332,322 |
| 2026-02-13 | 3,356,466 | +22.4% | 5.52 | 608,007 |
| 2026-01-30 | 2,741,979 | +6.3% | 5.89 | 465,420 |
| 2026-01-15 | 2,580,026 | -1.0% | 8.21 | 314,401 |
| 2025-12-31 | 2,605,655 | +17.1% | 5.22 | 499,038 |
| 2025-12-15 | 2,224,690 | +0.2% | 5.21 | 426,903 |
| 2025-11-28 | 2,220,820 | -8.9% | 5.72 | 388,477 |
| 2025-11-14 | 2,438,054 | +3.1% | 5.43 | 449,162 |
| 2025-10-31 | 2,363,802 | +2.5% | 8.66 | 272,925 |
| 2025-10-15 | 2,305,717 | -6.4% | 6.06 | 380,404 |
| 2025-09-30 | 2,463,784 | +50.8% | 3.33 | 740,935 |
import finzdata as yf
yf.Ticker("MAZE").short_interest # every report since 2017
yf.Client().short_interest(["MAZE"], start="2018-01-01")Healthcare short interest · MAZE price history · Who owns MAZE · All short interest